148 related articles for article (PubMed ID: 38482522)
21. Enzyme/GSH dual-responsive biodegradable nanohybrid for spatiotemporally specific photodynamic and hypoxia-augmented therapy against tumors.
Cheng D; Ji Y; Wang B; Jin T; Xu Y; Qian X; Zhu W
Int J Pharm; 2021 Jun; 603():120730. PubMed ID: 34029662
[TBL] [Abstract][Full Text] [Related]
22. Iodinated cyanine dye-based nanosystem for synergistic phototherapy and hypoxia-activated bioreductive therapy.
Dong Y; Zhou L; Shen Z; Ma Q; Zhao Y; Sun Y; Cao J
Drug Deliv; 2022 Dec; 29(1):238-253. PubMed ID: 35001784
[TBL] [Abstract][Full Text] [Related]
23. Mitochondrial Ca
Zhu J; Jiao A; Li Q; Lv X; Wang X; Song X; Li B; Zhang Y; Dong X
Acta Biomater; 2022 Jan; 137():252-261. PubMed ID: 34653696
[TBL] [Abstract][Full Text] [Related]
24. Tirapazamine combined with photodynamic therapy improves the efficacy of ABZSO nanoparticles on Echinococcosis granulosus via further enhancing "breaking-then-curing".
Gong Y; Zhou T; Aimaiti W; Lin Y; Xu Y; Yang J; Huang Z; Wen H; Jiang H; Wang J
J Photochem Photobiol B; 2023 Nov; 248():112798. PubMed ID: 37820499
[TBL] [Abstract][Full Text] [Related]
25. Cancer-Responsive Multifunctional Nanoplatform Based on Peptide Self-Assembly for Highly Efficient Combined Cancer Therapy by Alleviating Hypoxia and Improving the Immunosuppressive Microenvironment.
Wu J; Liu Y; Cao M; Zheng N; Ma H; Ye X; Yang N; Liu Z; Liao W; Sun L
ACS Appl Mater Interfaces; 2023 Feb; 15(4):5667-5678. PubMed ID: 36651290
[TBL] [Abstract][Full Text] [Related]
26. Tumor microenvironment-responsive nanohybrid for hypoxia amelioration with photodynamic and near-infrared II photothermal combination therapy.
Zhang P; Wu Q; Yang J; Hou M; Zheng B; Xu J; Chai Y; Xiong L; Zhang C
Acta Biomater; 2022 Jul; 146():450-464. PubMed ID: 35526739
[TBL] [Abstract][Full Text] [Related]
27. Near-infrared light triggered liposomes combining photodynamic and chemotherapy for synergistic breast tumor therapy.
Yang Y; Yang X; Li H; Li C; Ding H; Zhang M; Guo Y; Sun M
Colloids Surf B Biointerfaces; 2019 Jan; 173():564-570. PubMed ID: 30347383
[TBL] [Abstract][Full Text] [Related]
28. Cellular Hypoxia Mitigation by Dandelion-like Nanoparticles for Synergistic Photodynamic Therapy of Oral Squamous Cell Carcinoma.
Tao Y; Liu Y; Dong Z; Chen X; Wang Y; Li T; Li J; Zang S; He X; Chen D; Zhao Z; Li M
ACS Appl Mater Interfaces; 2022 Oct; 14(39):44039-44053. PubMed ID: 36153957
[TBL] [Abstract][Full Text] [Related]
29. Programmable therapeutic nanoscale covalent organic framework for photodynamic therapy and hypoxia-activated cascade chemotherapy.
He H; Du L; Xue H; Wu J; Shuai X
Acta Biomater; 2022 Sep; 149():297-306. PubMed ID: 35811069
[TBL] [Abstract][Full Text] [Related]
30. Hyaluronan-fullerene/AIEgen nanogel as CD44-targeted delivery of tirapazamine for synergistic photodynamic-hypoxia activated therapy.
Hong X; Xu X; Liu Z; Liu S; Yu J; Wu M; Ma Y; Shuai Q
Nanotechnology; 2021 Aug; 32(46):. PubMed ID: 34325415
[TBL] [Abstract][Full Text] [Related]
31. Silk fibroin-capped metal-organic framework for tumor-specific redox dyshomeostasis treatment synergized by deoxygenation-driven chemotherapy.
Yu H; Li Y; Zhang Z; Ren J; Zhang L; Xu Z; Kang Y; Xue P
Acta Biomater; 2022 Jan; 138():545-560. PubMed ID: 34775125
[TBL] [Abstract][Full Text] [Related]
32. Light-triggered theranostic liposomes for tumor diagnosis and combined photodynamic and hypoxia-activated prodrug therapy.
Zhang K; Zhang Y; Meng X; Lu H; Chang H; Dong H; Zhang X
Biomaterials; 2018 Dec; 185():301-309. PubMed ID: 30265899
[TBL] [Abstract][Full Text] [Related]
33. An albumin-binding dimeric prodrug nanoparticle with long blood circulation and light-triggered drug release for chemo-photodynamic combination therapy against hypoxia-induced metastasis of lung cancer.
Luo R; Zhang Z; Han L; Xue Z; Zhang K; Liu F; Feng F; Xue J; Liu W; Qu W
Biomater Sci; 2021 May; 9(10):3718-3736. PubMed ID: 34008617
[TBL] [Abstract][Full Text] [Related]
34. ROS-sensitive biomimetic nanocarriers modulate tumor hypoxia for synergistic photodynamic chemotherapy.
Liu H; Jiang W; Wang Q; Hang L; Wang Y; Wang Y
Biomater Sci; 2019 Aug; 7(9):3706-3716. PubMed ID: 31187794
[TBL] [Abstract][Full Text] [Related]
35. Enhanced photo-hypoxia-activated combination therapy traced by AIE photosensitizer and targeted by hyaluronic acid: Disulphide bond interference of detoxification barrier.
Ouyang F; Zhang X; Zhang L; Liu Y; Shuai Q
J Photochem Photobiol B; 2022 Sep; 234():112535. PubMed ID: 35930948
[TBL] [Abstract][Full Text] [Related]
36. Hypoxia-responsive nanoreactors based on self-enhanced photodynamic sensitization and triggered ferroptosis for cancer synergistic therapy.
Wang X; Wu M; Zhang X; Li F; Zeng Y; Lin X; Liu X; Liu J
J Nanobiotechnology; 2021 Jul; 19(1):204. PubMed ID: 34238297
[TBL] [Abstract][Full Text] [Related]
37. Developing Hypoxia-Sensitive System via Designing Tumor-Targeted Fullerene-Based Photosensitizer for Multimodal Therapy of Deep Tumor.
Li L; Fu J; Ye J; Liu L; Sun Z; Wang H; Tan S; Zhen M; Wang C; Bai C
Adv Mater; 2024 Jun; 36(23):e2310875. PubMed ID: 38450765
[TBL] [Abstract][Full Text] [Related]
38. Cancer cell membrane-coated biomimetic platform for tumor targeted photodynamic therapy and hypoxia-amplified bioreductive therapy.
Li SY; Cheng H; Qiu WX; Zhang L; Wan SS; Zeng JY; Zhang XZ
Biomaterials; 2017 Oct; 142():149-161. PubMed ID: 28735175
[TBL] [Abstract][Full Text] [Related]
39. Ferroptosis Promotes Photodynamic Therapy: Supramolecular Photosensitizer-Inducer Nanodrug for Enhanced Cancer Treatment.
Zhu T; Shi L; Yu C; Dong Y; Qiu F; Shen L; Qian Q; Zhou G; Zhu X
Theranostics; 2019; 9(11):3293-3307. PubMed ID: 31244955
[TBL] [Abstract][Full Text] [Related]
40. Self-Rectifiable and Hypoxia-Assisted Chemo-Photodynamic Nanoinhibitor for Synergistic Cancer Therapy.
Wang Y; Huo J; Li S; Huang R; Fan D; Cheng H; Wan B; Du Y; He H; Zhang G
ACS Appl Mater Interfaces; 2022 Mar; 14(8):10092-10101. PubMed ID: 35170301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
